Skip to main content

Tipp

Weitere Artikel dieser Ausgabe durch Wischen aufrufen

Erschienen in: memo - Magazine of European Medical Oncology 2/2017

01.06.2017 | case report

Primary signet cell carcinoma of the prostate: a case report

verfasst von: Mustafa Sungur, Aykut Buğra Şentürk, Selahattin Çalışkan, Abdullah Gürel

Erschienen in: memo - Magazine of European Medical Oncology | Ausgabe 2/2017

Einloggen, um Zugang zu erhalten
share
TEILEN

Summary

Primary signet cell carcinoma of the prostate is very rare histological variant and usually originates from the stomach, colon, and pancreas. This malignancy was first reported in 1979 and there have been case series with small numbers of patients and case reports in the literature. Signet cell carcinoma of the prostate has a poor outcome when compared to classic prostate adenocarcinoma. A case of primary signet cell carcinoma of the prostate that was treated with maximal androgen deprivation therapy with zoledronic acid is reported.
Literatur
1.
Zurück zum Zitat Kwon WA, Oh TH, Ahn SH, Lee JW, Park SC. Primary signet ring cell carcinoma of the prostate. Can Urol Assoc J. 2013;7:768–71. CrossRef Kwon WA, Oh TH, Ahn SH, Lee JW, Park SC. Primary signet ring cell carcinoma of the prostate. Can Urol Assoc J. 2013;7:768–71. CrossRef
2.
Zurück zum Zitat Celik O, Budak S, Ekin G, Akarken I, Ilbey YO. A case with primary signet ring cell adenocarcinoma of the prostate and review of the literature. Arch Ital Urol Androl. 2014;86:148–9. CrossRefPubMed Celik O, Budak S, Ekin G, Akarken I, Ilbey YO. A case with primary signet ring cell adenocarcinoma of the prostate and review of the literature. Arch Ital Urol Androl. 2014;86:148–9. CrossRefPubMed
3.
Zurück zum Zitat Torbenson M, Dhir R, Nangia A, et al. Prostatic carcinoma with signet ring cells; a clinicopathologic and immunohistochemical analysis of 12 cases, with review of the literature. Mod Pathol. 1998;11:552–9. PubMed Torbenson M, Dhir R, Nangia A, et al. Prostatic carcinoma with signet ring cells; a clinicopathologic and immunohistochemical analysis of 12 cases, with review of the literature. Mod Pathol. 1998;11:552–9. PubMed
4.
Zurück zum Zitat Fujita K, Sugao H, Gotoh T, et al. Primary signet ring cell carcinoma of the prostate: report and review of 42 cases. Int J Urol. 2004;11:178–81. CrossRefPubMed Fujita K, Sugao H, Gotoh T, et al. Primary signet ring cell carcinoma of the prostate: report and review of 42 cases. Int J Urol. 2004;11:178–81. CrossRefPubMed
5.
Zurück zum Zitat Roldán AM, Nú-ez NF, Grande E, et al. A primary signet ring cell carcinoma of the prostate with bone metastasis with impressive response to FOLFOX and cetuximab. Clin Genitourin Cancer. 2012;10:199–201. CrossRefPubMed Roldán AM, Nú-ez NF, Grande E, et al. A primary signet ring cell carcinoma of the prostate with bone metastasis with impressive response to FOLFOX and cetuximab. Clin Genitourin Cancer. 2012;10:199–201. CrossRefPubMed
6.
Zurück zum Zitat Lilleby W, Axcrona K, Alfsen GC, et al. Diagnosis and treatment of primary signet ring cell carcinoma of the prostate. Acta Oncol. 2007;46:1195–7. CrossRefPubMed Lilleby W, Axcrona K, Alfsen GC, et al. Diagnosis and treatment of primary signet ring cell carcinoma of the prostate. Acta Oncol. 2007;46:1195–7. CrossRefPubMed
7.
Zurück zum Zitat Akagashi K, Tanda H, Kato S, Ohnishi S, Nakajima H, Nanbu A, Nitta T, Koroku M. Signet-ring cell carcinoma of the prostate effectively treated with maximal androgen blockade. Int J Urol. 2003;10:456–8. CrossRefPubMed Akagashi K, Tanda H, Kato S, Ohnishi S, Nakajima H, Nanbu A, Nitta T, Koroku M. Signet-ring cell carcinoma of the prostate effectively treated with maximal androgen blockade. Int J Urol. 2003;10:456–8. CrossRefPubMed
8.
Zurück zum Zitat Kanematsu A, Hiura M. Primary signet ring cell adenocarcinoma of the prostate treated by radical prostatectomy after preoperative androgen deprivation. Int J Urol. 1997;4:522–3. CrossRefPubMed Kanematsu A, Hiura M. Primary signet ring cell adenocarcinoma of the prostate treated by radical prostatectomy after preoperative androgen deprivation. Int J Urol. 1997;4:522–3. CrossRefPubMed
Metadaten
Titel
Primary signet cell carcinoma of the prostate: a case report
verfasst von
Mustafa Sungur
Aykut Buğra Şentürk
Selahattin Çalışkan
Abdullah Gürel
Publikationsdatum
01.06.2017
Verlag
Springer Vienna
Erschienen in
memo - Magazine of European Medical Oncology / Ausgabe 2/2017
Print ISSN: 1865-5041
Elektronische ISSN: 1865-5076
DOI
https://doi.org/10.1007/s12254-017-0327-3

Weitere Artikel der Ausgabe 2/2017

memo - Magazine of European Medical Oncology 2/2017 Zur Ausgabe